IGFBP6 antibody; IBP6 antibody; Insulin-like growth factor-binding protein 6 antibody; IBP-6 antibody; IGF-binding protein 6 antibody; IGFBP-6 antibody;
Product description
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. PTM:O-linked glycans consist of hexose (probably Gal), N-acetylhexosamine (probably GalNAc) and sialic acid residues. Major glycoforms consist of 8-16 monosaccharides (by homology to IGFBP6 expressed recombinantly in CHO cells). Contains 1 IGFBP N-terminal domain. Contains 1 thyroglobulin type-1 domain.
Immunogen
The antiserum was produced against synthesized peptide derived from the Internal region of human IGFBP6. AA range:101-150
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WB
WB:1:500-1:2000
Species Reactivity
Human
Concentration
1mg/ml
Target Information
Alternative Names
IGFBP6 antibody IBP6 antibody Insulin-like growth factor-binding protein 6 antibody IBP-6 antibody IGF-binding protein 6 antibody IGFBP-6 antibody